Clinical Pharmacy and Adverse Drug Reactions focuses on the identification, management, and prevention of adverse drug reactions (ADRs) in clinical settings. It covers ADR monitoring systems, risk assessment strategies, and interventions to minimize harm from medications. The book emphasizes the pharmacist's role in enhancing drug safety and patient education to prevent and manage ADRs. Suitable for clinical pharmacists and healthcare providers, it advances practices to ensure medication safety and reduce adverse outcomes.
Dylan Ali is a Clinical Pharmacist specializing in adverse drug reaction (ADR) management and pharmacovigilance. He has published 35 articles and edited 2 books on ADR monitoring. Dylan’s research explores identifying and mitigating medication risks in diverse patient populations. His work underscores the importance of pharmacist-led safety initiatives.